Clicky

Carelabs Co.Ltd(263700)

Description: Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform; and BNK Lab that provides dating app services. The company also offers GOODOC, a healthcare integrated platform that allows to search, review, reserve, receive, and follow-up management of various medical services, such as hospitals/pharmacies/beauty based on a mobile environment; and BeautyCon, a multilingual AI molding platform that analyzes user information and usage behavior through artificial intelligence and recommends domestic plastic surgeons, doctors, and procedures suitable for users. In addition, it manufactures and supplies solutions for hospital customers and operation management; develops and distributes health functional foods and nutritional supplements; and develops various customer service solutions, as well as provides IT solutions to pharmacies and hospitals; management consulting, marketing, and medical device distribution services; O2O commerce for beauty tours and concierge services for foreign patients. The company was formerly known as Vibe ALS Corporation and changed its name to Carelabs Co.,Ltd in November 2016. Carelabs Co.,Ltd is based in Seoul, South Korea.


Keywords: Artificial Intelligence Medical Services Plastic Surgery Operation Management Economy Of Ontario Concierge Services Digital Marketing Solutions Follow Up Management Customer Service Solutions

Home Page: www.carelabs.co.kr

Care-Lab Tower
Seoul,
South Korea
Phone: 82 2 6929 2340


Exchange: KQ

Country: KR : Korea (Republic of)

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0.7569
IPO Date:
Fiscal Year End: December
Full Time Employees: 122
Back to stocks